No definition available.
Brain astrocytoma, excluding all cancers (controls excluding all cancers)
C3_ASTROCYTOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
143 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
143 |
4. Check minimum number of eventsNone |
143 |
5. Include endpoints |
143 |
6. Filter based on genotype QC (FinnGen only) |
143 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_ASTROCYTOMA
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Brain astrocytoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Brain astrocytoma
- Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)
- Brain glioblastoma and astrocytoma
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 143 | 71 | 72 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 40.81 | 38.49 | 43.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 135
- Matched controls
- 1350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
128.5
102
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
+∞
125.3
100
*
L01AX03
ATC
temozolomide; systemic
+∞
112.9
92
*
H02AB02
ATC
dexamethasone; systemic
604.3
108.1
94
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
163.9
105.9
106
29
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
65.8
79.6
94
45
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
77.8
67
*
N03AX14
ATC
levetiracetam; systemic
128.9
76.8
78
14
A04AA02
ATC
granisetron; systemic, transdermal
+∞
75.2
65
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
168.4
73.2
72
9
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
58.7
52
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
53.8
48
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
53.8
48
*
A03FA01
ATC
metoclopramide; systemic, rectal
28.9
53.1
77
59
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
51.4
46
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
107.5
50.7
53
8
ZXC95
NOMESCO Finland
Use of surgical navigator
680.2
49.7
46
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
49.0
44
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
49.0
44
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
87.0
46.4
50
9
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
322.6
46.0
44
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
118.5
45.4
47
6
N03AF02
ATC
oxcarbazepine; oral
45.8
41.2
50
17
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
36.1
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
32.5
34.8
46
21
R56.8
ICD-10 Finland
Other and unspecified convulsions
22.7
34.2
51
35
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
32.6
30
*
AA1AD
NOMESCO Finland
CT of head and brain
10.3
31.4
76
150
XA800
NOMESCO Finland
Neuropsychological investigation
25.5
31.1
44
25
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
30.4
28
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
29.2
27
*
A04AA01
ATC
ondansetron; systemic, rectal
35.8
27.5
35
13
ZXC40
NOMESCO Finland
Use of ultrasound
319.0
26.7
26
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
29.5
24.0
32
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
9.4
23.7
55
92
N03AB02
ATC
phenytoin; systemic
274.7
23.4
23
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
10.7
23.0
48
66
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
22.5
21
*
Z51.5
ICD-10 Finland
Palliative care
260.5
22.3
22
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
260.5
22.3
22
*
N03AX18
ATC
lacosamide; systemic
91.3
21.4
23
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
21.4
20
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
130.3
21.3
22
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
20.3
19
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.9
19.9
75
237
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
19.2
18
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
58.2
17.5
20
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
32.4
17.1
22
8
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
17.0
16
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
38.7
16.3
20
6
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
15.9
15
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
15.9
15
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
15.9
15
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
43.8
15.9
19
5
WX882
NOMESCO Finland
High dependency care
19.9
14.9
22
13
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
14.9
14
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
14.9
14
*
N03AG01
ATC
valproic acid; systemic, rectal
9.0
14.3
31
43
A02BC02
ATC
pantoprazole; systemic
4.4
14.3
100
528
N05BA09
ATC
clobazam; oral
83.5
13.9
15
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
13.8
13
*
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
13.8
13
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
35.9
12.9
16
5
183
Kela drug reimbursment
Lamotrigin and topiramate
77.4
12.8
14
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
77.4
12.8
14
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
12.7
12
*
H53.4
ICD-10 Finland
Visual field defects
41.8
12.5
15
*
N03AF01
ATC
carbamazepine; oral, rectal
11.7
12.0
22
22
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.6
11
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
11.6
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
11.6
11
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
130.7
11.6
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.4
11.6
48
150
WZC30
NOMESCO Finland
Teaching
6.7
11.1
29
53
G40.10
ICD-10 Finland
Simple partial seizures
118.9
10.6
11
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
10.5
10
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
10.5
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
10.5
10
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.5
10
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
10.5
10
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
25.8
10.5
14
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
32.6
9.6
12
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
9.5
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.5
9
*
WX872
NOMESCO Finland
Intensive care
9.7
9.1
18
21
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
26.1
9.1
12
5
WX402
NOMESCO Finland
General anaesthesia
4.4
8.9
34
96
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.7
8.5
41
142
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.4
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
84.5
7.5
8
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
7.4
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.4
7
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
7.4
7
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
7.4
7
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
7.4
7
*
N03AX23
ATC
brivaracetam; systemic
+∞
7.4
7
*
G40
ICD-10 Finland
Epilepsy
31.9
7.2
9
*
H02AB09
ATC
hydrocortisone; systemic
14.8
7.0
11
8
R4130
NOMESCO Finland
Speech therapy
17.8
6.9
10
6
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
23.9
6.8
9
*
JN4CD
NOMESCO Finland
Very extensive body CT
73.2
6.5
7
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
6.3
27
84
N76
ICPC
Neoplasm nervous system unspecified
+∞
6.3
6
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
6.3
6
*
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
6.3
6
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
82
31
60.67
128.58
1.4
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
70
87
14.80
58.01
5.5
15.3
mmol/l
0.8
1.7
1.23
51
68
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
50
43
17.34
51.87
4.0
7.6
mmol/l
23.8
25.4
1.64
50
43
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
9
69.77
39.39
2.0
2.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
107
442
6.64
24.66
6.7
6.6
mmol/l
1.2
1.2
1.06
95
387
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
16
16.07
24.19
2.0
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
236
5.43
22.78
1.9
1.8
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
0
+∞
22.48
1.0
0.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
84
308
5.19
21.54
2.2
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
359
5.22
21.20
3.3
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
15
13.58
18.15
1.8
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
29
48
7.32
17.63
5.9
13.9
%
96.4
93.9
3.28
29
48
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
100
477
4.65
16.95
3.3
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
78
321
4.15
16.02
4.0
6.9
inr
1.0
1.2
1.62
20
85
(3044290) Cell count panel - Cerebral spinal fluid
22
30
8.48
15.72
1.9
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
642
4.26
12.81
16.6
7.2
e9/l
3.4
4.2
4.61
100
564
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
42
6.33
12.58
7.7
23.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
8
23.88
12.34
1.8
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
282
3.49
12.08
7.5
2.1
mmol/l
2.4
2.4
0.67
59
240
(42870588) Differential panel, method unspecified - Blood
76
358
3.40
11.82
8.6
6.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
20
35
6.48
11.36
1.7
1.1
e6/l
34.3
2.2
1.23
14
26
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
20
35
6.48
11.36
1.8
1.3
e6/l
1025.9
32.6
0.48
15
28
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
0
+∞
10.54
1.0
0.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
51
4.92
9.24
5.4
14.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
96
578
3.01
8.88
9.1
6.5
e9/l
0.1
0.2
11.97
85
521
(3001604) Monocytes [#/volume] in Blood
94
562
2.96
8.77
9.1
6.1
e9/l
0.5
0.5
0.43
83
499
(3006315) Basophils [#/volume] in Blood
94
563
2.95
8.72
9.2
6.1
e9/l
0.0
0.0
4.75
82
502
(3019069) Monocytes/100 leukocytes in Blood
90
532
2.87
8.47
9.4
6.6
%
9.3
8.4
1.91
90
509
(3022096) Basophils/100 leukocytes in Blood
88
516
2.83
8.38
9.3
6.4
%
0.5
0.7
4.17
88
487
(3006504) Eosinophils/100 leukocytes in Blood
89
527
2.82
8.28
9.2
6.2
%
2.1
3.0
4.61
89
502
(3018010) Neutrophils/100 leukocytes in Blood
90
542
2.78
8.01
9.3
6.1
%
60.0
57.0
1.29
90
518
(3002030) Lymphocytes/100 leukocytes in Blood
90
550
2.72
7.65
9.5
6.3
%
26.3
29.2
1.43
90
525
(3019198) Lymphocytes [#/volume] in Blood
93
582
2.71
7.46
9.3
6.2
e9/l
1.4
1.9
9.17
83
523
(3003694) ABO and Rh group [Type] in Blood
64
344
2.56
6.90
1.3
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
69
3.78
6.90
8.0
9.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
47
218
2.72
6.82
3.4
4.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
15
7.09
6.40
1.9
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
91
1159
0.41
5.81
2.8
3.8
mmol/l
4.8
4.7
0.48
81
1095
(40758558) Short blood count panel - Blood
50
257
2.45
5.75
10.0
5.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
91
1154
0.42
5.54
2.8
3.7
mmol/l
1.4
1.4
0.51
81
1088
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
93
1169
0.42
5.53
2.9
4.1
mmol/l
3.0
2.9
0.75
81
1096
(3021589) Normoblasts [#/volume] in Blood
74
462
2.25
5.34
12.8
7.7
e9/l
0.0
0.0
0.48
62
372
(3018418) pH of Serum or Plasma
49
265
2.29
4.92
2.6
2.7
ph
7.4
7.4
—
9
31
(3013512) EKG study
44
229
2.33
4.82
3.2
3.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
89
1113
0.47
4.36
2.8
3.4
mmol/l
1.3
1.3
0.17
80
1038
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
58
356
2.06
4.12
2.7
3.0
ng/l
13.8
36.0
1.62
38
189
(3019225) pH of Specimen
20
78
2.82
3.92
3.3
4.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
5
12.44
3.79
3.0
6.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
5
12.44
3.79
1.5
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
72
947
0.52
3.66
3.3
3.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
17
69
2.66
3.09
3.8
4.6
%
1.8
0.6
—
9
16
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
104
2.32
2.93
7.6
7.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
76
0.00
2.84
0.0
1.2
—
506.1
—
0
70
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
18
4.64
2.84
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
99
1155
0.54
2.81
27.0
11.6
%
38.7
41.4
1.71
76
957
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
19
4.39
2.72
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
11
263
0.37
2.71
2.5
4.1
mg/mmol
1.9
10.0
—
5
179
(3020891) Body temperature
10
33
3.18
2.58
3.0
6.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
7
7.35
2.57
1.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
16
4.54
2.50
3.1
2.1
kpa
8.8
8.4
—
7
16
(3013290) Carbon dioxide [Partial pressure] in Blood
7
16
4.54
2.50
3.1
2.1
kpa
5.2
4.8
—
7
16
(3012501) Base excess in Blood by calculation
7
16
4.54
2.50
3.1
2.1
mmol/l
2.3
1.9
—
7
10
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
85
1024
0.58
2.49
3.2
4.7
mmol/mol
35.9
38.7
4.33
74
979
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
17
4.27
2.39
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
48
2.64
2.25
3.5
2.8
mmol/l
1.2
1.2
0.30
12
41
(3022806) Fractional oxyhemoglobin in Capillary blood
5
9
5.71
2.23
1.4
1.1
%
93.0
91.8
—
5
9
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
93
1085
0.59
2.22
3.6
3.7
mmol/l
5.5
5.8
2.73
84
1007
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
31
3.03
2.11
1.2
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.14
2.09
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
135
1.93
2.07
1.8
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
39
2.68
1.96
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
16
3.86
1.95
2.8
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
14
65
2.28
1.95
3.4
4.7
%
0.1
0.1
—
7
13
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
51
0.00
1.93
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
52
0.00
1.92
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
52
0.00
1.92
0.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
239
1.68
1.81
2.2
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.94
1.73
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
49
2.35
1.68
1.0
1.5
—
—
—
0
0
(3015736) pH of Urine
30
435
0.61
1.63
3.2
2.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.59
1.62
1.1
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
127
1155
1.89
1.61
22.6
11.2
mmol/l
139.1
139.7
1.15
127
1124
(21494755) Public health laboratory ask at order entry panel
10
201
0.46
1.59
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
199
0.47
1.55
1.8
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
127
1158
1.86
1.55
21.8
11.3
mmol/l
3.9
3.9
1.56
127
1125
(3003338) MCHC [Mass/volume]
98
1101
0.65
1.52
30.8
13.3
g/l
336.4
334.4
1.12
98
1096
(3010813) Leukocytes [#/volume] in Blood
128
1349
0.51
1.46
34.3
14.9
e9/l
6.5
6.6
0.18
128
1317
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
120
0.40
1.45
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
289
0.57
1.43
1.7
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
128
1348
0.52
1.42
34.2
14.8
pg
30.5
30.2
1.41
128
1330
(3024731) MCV [Entitic volume]
128
1348
0.52
1.42
34.3
14.9
fl
90.7
90.1
0.79
128
1330
(3000963) Hemoglobin [Mass/volume] in Blood
128
1348
0.52
1.42
35.3
15.0
g/l
135.9
139.7
2.47
128
1329
(3031040) Bacteria [#/volume] in Urine by Automated count
81
675
1.46
1.41
3.2
3.7
—
49.4
—
0
9
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
17
3.01
1.37
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
34
462
0.65
1.34
1.9
2.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
128
1346
0.53
1.33
34.3
14.9
e9/l
246.4
252.6
0.29
128
1317
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
19
2.69
1.22
1.2
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
33
0.00
1.18
0.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
35
0.00
1.17
0.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
35
0.00
1.17
0.0
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
16
96
1.75
1.16
1.7
1.6
—
—
—
0
0
(4094501)
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
36
0.00
1.15
0.0
1.2
—
18.4
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
121
0.47
1.11
1.2
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
117
1073
1.50
1.05
19.2
8.6
ml/min/173m2
98.9
91.5
4.23
106
838
(3019832) Treponema pallidum Ab [Presence] in Serum
13
209
0.58
1.03
1.3
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
86
751
1.36
1.01
3.1
3.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
29
0.00
0.99
0.0
1.1
—
0.0
—
0
29
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
62
1.84
0.97
1.4
2.6
g/l
0.3
0.2
0.80
11
56
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
155
0.55
0.95
1.3
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
6
27
2.27
0.94
2.7
2.3
g/l
3.3
4.0
—
6
27
(3000492) Spirometry study
7
129
0.52
0.93
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
130
0.51
0.93
1.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
96
1.63
0.88
2.0
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
140
0.55
0.88
2.4
2.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
28
366
0.71
0.86
1.9
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
131
1.52
0.83
1.2
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
157
1.47
0.83
2.9
2.3
e6/l
4.8
2.6
0.30
14
77
(3044889) 12 lead EKG panel
79
694
1.31
0.83
2.9
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
8
47
1.74
0.82
1.4
3.0
—
7.4
—
0
5
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
193
1.42
0.81
2.0
3.3
ng/l
1867.0
712.0
—
10
128
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
24
0.00
0.80
0.0
1.1
—
0.0
—
0
24
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
24
0.00
0.80
0.0
1.1
—
0.0
—
0
24
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
125
1178
1.49
0.80
20.1
10.2
mg/l
19.6
20.8
0.21
116
889
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.79
0.0
1.2
—
4.6
—
0
14
(40760892) CBC W Ordered Manual Differential panel - Blood
34
266
1.36
0.78
7.4
4.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
25
2.04
0.73
1.0
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
11
168
0.63
0.73
2.3
2.4
ug/l
0.8
0.8
—
5
97
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
202
0.66
0.72
1.4
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
162
1.42
0.71
2.8
2.2
e6/l
0.8
0.8
0.04
14
82
(3035350) Ketones [Presence] in Urine by Test strip
45
533
0.77
0.70
2.8
2.9
estimate
0.0
0.0
—
8
91
(3022145) Colonoscopy Study observation
7
112
0.61
0.61
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
64
1.60
0.60
2.0
2.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(4306422)
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
99
1058
0.79
0.59
3.9
4.3
mu/l
1.7
1.7
0.38
92
987
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
86
0.57
0.58
2.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
86
0.57
0.58
2.6
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
270
0.74
0.58
2.0
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
46
531
0.80
0.56
4.3
4.2
estimate
0.0
0.0
—
8
89
(3036489) Thrombin time
6
38
1.60
0.55
2.3
1.9
s
20.5
20.7
—
6
33
(3009261) Glucose [Presence] in Urine by Test strip
47
539
0.81
0.53
2.9
3.0
estimate
0.0
0.0
—
8
87
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
64
1.43
0.52
1.7
1.3
iu/l
18.6
23.0
—
9
59
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
243
0.75
0.51
1.9
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
102
1.41
0.49
2.3
2.4
—
22.1
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
283
0.78
0.47
1.4
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
272
0.77
0.47
1.0
1.3
g/l
1.7
2.4
—
10
158
(3027008) Opiates [Presence] in Urine
5
85
0.57
0.47
2.6
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
51
1.39
0.44
1.7
1.5
u/l
10.2
6.8
—
7
42
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
227
0.76
0.44
2.3
3.3
%
22.5
24.2
—
7
93
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
31
1.63
0.43
2.8
2.2
%
185.4
181.7
—
5
31
(3022313) Gas panel - Capillary blood
5
32
1.58
0.42
1.6
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
347
1.21
0.42
2.4
2.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
33
1.53
0.42
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
33
1.53
0.42
1.4
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
17
0.00
0.41
0.0
3.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
3.0
—
—
—
0
0
(4268621)
0
19
0.00
0.39
0.0
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
244
0.79
0.39
2.6
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
32
274
1.22
0.38
2.5
2.4
e6/l
0.1
0.2
0.51
24
201
(36304419) Bacteria [Presence] in Urine
32
274
1.22
0.38
2.0
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
421
0.84
0.37
3.2
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
39
441
0.84
0.37
2.2
2.3
nmol/l
77.3
73.6
0.36
34
407
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
77
0.64
0.37
1.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
79
0.62
0.36
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
17
137
1.27
0.34
1.9
1.6
nmol/l
1369.3
1093.5
—
9
107
(40761535) Cells panel - Urine sediment
10
76
1.34
0.29
2.0
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
120
0.73
0.28
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
63
1.29
0.28
1.8
1.9
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
72
0.68
0.27
1.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
72
0.68
0.27
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
72
0.68
0.27
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
72
0.68
0.27
1.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
98
1020
0.88
0.26
28.7
12.2
%
13.4
13.4
0.02
98
1002
(3025941) Bacteria identified in Stool by Culture
5
74
0.66
0.26
1.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
73
1.25
0.26
3.7
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
48
520
0.88
0.25
2.0
2.7
ug/l
91.0
86.6
0.09
42
496
(3050129) First trimester maternal screen panel - Serum or Plasma
6
81
0.73
0.25
1.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
156
0.82
0.22
1.5
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
10
0.00
0.21
0.0
4.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
153.5
—
0
12
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
9.6
—
0.6
—
0
12
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
311
0.88
0.21
2.8
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
24
269
0.87
0.20
2.9
3.3
estimate
0.0
0.0
—
8
89
(3002582) Erythrocytes [#/volume] in Urine
34
310
1.13
0.20
2.5
2.3
e6/l
26.2
270.9
0.61
26
236
(3042936) Bacteria identified in Isolate by Culture
11
131
0.83
0.18
1.1
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
77
0.77
0.16
2.0
2.4
ug/l
10.1
9.6
—
6
68
(36660697) Celiac disease serology panel - Serum
14
121
1.17
0.15
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8
98
0.81
0.14
1.0
1.3
iu/ml
—
145.0
—
0
36
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
105
0.85
0.13
1.6
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
198
0.90
0.11
1.4
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
43
1.17
0.10
5.6
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
83
848
0.95
0.08
3.6
3.8
pmol/l
14.3
14.5
0.31
77
794
(3002256) Pathology report gross observation
9
101
0.88
0.06
1.3
1.1
—
—
—
0
0
(3012544) pH of Venous blood
10
90
1.12
0.05
1.7
3.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
23
242
0.94
0.05
1.3
1.7
mg/l
0.7
1.0
0.69
13
180
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
110
1.10
0.05
3.9
3.8
%
24.9
31.1
—
7
69
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
371
0.96
0.04
1.7
1.8
pmol/l
99.2
98.1
0.05
19
190
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
86
871
0.97
0.03
3.6
2.8
u/l
46.7
41.5
0.36
80
839
(40761511) CBC panel - Blood by Automated count
126
1261
0.99
0.00
20.6
9.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
123
0.97
0.00
1.3
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
1273
0.98
0.00
18.1
7.9
u/l
28.1
28.3
0.04
127
1240
(3018095) Leukocytes [#/volume] in Urine
37
372
0.99
0.00
2.8
2.8
e6/l
49.5
75.2
0.22
27
250
(40761536) Microorganisms panel - Urine sediment
8
82
0.97
0.00
2.4
3.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
9
0.00
0.00
0.0
1.0
—
13.7
—
0
9
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
13.5
—
0
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
142.0
—
0
7
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.7
—
8.1
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
6.8
—
0
5
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
578.8
—
0
8
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(4146454)
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.8
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
202.2
—
0
5
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
3.6
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
293.3
—
0
8
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_ASTROCYTOMA_EXALLC – Brain astrocytoma, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).